Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 17.36 is 203% above its 4-year average of 5.72, near the high end of its 4-year range (0.00–17.36).
As of the fiscal period ended Tuesday, June 30, 2026. 39.11% above its 12-month average of 12.48.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 17.36.
QUICK RATIO (ACID-TEST)
17.36
QUICK RATIO (ACID-TEST) AVG TTM
12.48
QUICK RATIO (ACID-TEST) AVG 3Y
7.24
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+39.11%
CURRENT VS 3Y AVG
+139.77%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+418.20%
vs the sector median at left
iTonic Holdings Ltd.
Market Cap
$28.03M
Quick Ratio (Acid-Test)
17.36
TTM Avg
12.48
3Y Avg
7.24
5Y Avg
N/A
Market Cap
$25.22M
Quick Ratio (Acid-Test)
0.07
TTM Avg
0.37
3Y Avg
0.39
5Y Avg
0.82
Market Cap
$24.69M
Quick Ratio (Acid-Test)
3.52
TTM Avg
5.18
3Y Avg
5.31
5Y Avg
5.55
Market Cap
$24.44M
Quick Ratio (Acid-Test)
5.69
TTM Avg
10.26
3Y Avg
14.54
5Y Avg
17.67
Market Cap
$27.79M
Quick Ratio (Acid-Test)
5.12
TTM Avg
5.39
3Y Avg
5.72
5Y Avg
7.97
Market Cap
$28.03M
Quick Ratio (Acid-Test)
0.33
TTM Avg
0.24
3Y Avg
0.87
5Y Avg
2.84
Market Cap
$28.47M
Quick Ratio (Acid-Test)
2.11
TTM Avg
1.75
3Y Avg
1.81
5Y Avg
2.79
Market Cap
$24.13M
Quick Ratio (Acid-Test)
2.59
TTM Avg
2.35
3Y Avg
1.92
5Y Avg
2.36
Market Cap
$28.31M
Quick Ratio (Acid-Test)
0.28
TTM Avg
0.31
3Y Avg
0.17
5Y Avg
0.17
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| iTonic Holdings Ltd. (ITOC) | $28.03M | 17.36 | 12.48 | 7.24 | N/A |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.22M | 0.07 | 0.37 | 0.39 | 0.82 |
| InspireMD, Inc. (NSPR)vs › | $24.69M | 3.52 | 5.18 | 5.31 | 5.55 |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.44M | 5.69 | 10.26 | 14.54 | 17.67 |
| aTyr Pharma, Inc. (ATYR)vs › | $27.79M | 5.12 | 5.39 | 5.72 | 7.97 |
| Tevogen Bio Holdings Inc. (TVGN)vs › | $28.03M | 0.33 | 0.24 | 0.87 | 2.84 |
| Seres Therapeutics, Inc. (MCRB)vs › | $28.47M | 2.11 | 1.75 | 1.81 | 2.79 |
| Kyntra Bio, Inc. (KYNB)vs › | $24.13M | 2.59 | 2.35 | 1.92 | 2.36 |
| OneMedNet Corporation (ONMD)vs › | $28.31M | 0.28 | 0.31 | 0.17 | 0.17 |
| TherapeuticsMD, Inc. (TXMD)vs › | $23.26M | 3.22 | 2.47 | 1.96 | 1.72 |
Quick Ratio
17.36
Excludes inventory
Current Ratio
17.39
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 17.36 |
| 2025-12-31 | 8.72 |
| 2025-06-30 | 11.36 |
| 2024-12-31 | 12.18 |
| 2024-06-30 | 0.20 |
| 2023-12-31 | 0.40 |
| 2023-06-30 | 0.47 |
| 2022-12-31 | 0.83 |
| 2022-06-30 | 0.00 |
